+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up

Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up

Dermatology 192(4): 343-346

Methotrexate (MTX) may induce liver damage, which in some psoriatics will lead to fibrosis or cirrhosis. Studies performed 10 years ago on 25 patients with MTX-induced liver cirrhosis indicated that this type of cirrhosis was not of an aggressive nature. The aim of this study was to evaluate the present status of surviving patients 10 years later, together with the latest clinical and histological data on patients who had died. The investigations were carried out on 186 liver biopsies and 5 autopsies. All biopsies were studied by the same pathologist. Eleven surviving patients were also studied by analysis of serum aminoterminal propeptide of type III procollagen (PIIINP), which is an indicator of fibrogenesis, which is especially suitable for follow-up of fibrotic liver disease. Thirteen patients had died; 1 of these died of liver failure. Another patient died form an overdose due to misunderstanding of the prescribed dosage given elsewhere. The remaining deaths were non-MTX related, but all 5 autopsies showed some degree of cirrhosis. On the other hand, 13 patients had no histologically verified liver cirrhosis in their latest biopsy, and PIIINP was within the normal range in all 11 patients investigated, this in spite of total cumulative MTX doses from 1,120 to 18,645 mg (mean 7,171 mg). This study confirmed that in most patients MTX-induced liver cirrhosis is not aggressive. However, continued low-dose MTX led, in spite of normal liver tests, 8 years after the last biopsy to liver failure and death in 1 of our patients. Our data support the continued use of liver biopsies in the surveillance of MTX-treated psoriatics.

(PDF emailed within 1 workday: $29.90)

Accession: 046676792

Download citation: RISBibTeXText

PMID: 8864370

Related references

Studies on further attenuated liver measles vaccine. VI. Clinical and serological follow-up one year after vaccination. Biken Journal 14(3): 247-251, 1971

Methotrexate-induced liver cirrhosis. A follow-up. Dermatologica 175(4): 178-182, 1987

Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R. Hepatology 65(2): 647-660, 2016

Methotrexate induced liver cirrhosis studies including serial liver biopsies during continued treatment. British Journal of Dermatology 102(4): 407-412, 1980

Five-year follow-up of clinical and laboratory data of early liver cirrhosis patients confirmed by liver biopsy. Taehan Kan Hakhoe Chi 8(3): 256-263, 2002

Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study. Liver Transplantation 7(7): 588-595, 2001

Liver transplantation for alcohol-related cirrhosis: a single centre long-term clinical and histological follow-up. Digestive Diseases and Sciences 56(1): 236-243, 2011

Prognosis of liver cirrhosis: results of a 14-year-long clinical follow-up study. Schweizerische Medizinische Wochenschrift 113(43): 1586-1592, 1983

Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study. Hepato-Gastroenterology 27(3): 169-175, 1980

Follow-up studies on an unselected ten-year material of 360 patients with liver cirrhosis in one community. Acta Medica Scandinavica 173: 479-493, 1963

Histological and biochemical studies on the experimental liver cirrhosis induced by peptone. Tokushima Jour Exptl Med 6(3): 207-230, 1959

Clinical and histological studies on cirrhosis of the liver at the First Tokyo National Hospital. Iryo 22(11): 1296-1307, 1968

The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: A 10-year follow-up. British Journal of Dermatology 144(1): 100-103, 2001

Methotrexate therapy for primary biliary cirrhosis Five year follow-up. Hepatology 28(4 PART 2): 545A, 1998

Two year histologic follow-up of the effects of methotrexate on primary biliary cirrhosis. Hepatology 22(4 PART 2): 124A, 1995